---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-25-000217"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:37:49.297656+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Executive chairman's Q&A highlights Clover's PPO success and AI edge

## Summary
- Vivek Garipalli answers two shareholder questions on PPO model viability and AI in healthcare.
- Clover claims its PPO model succeeds by building Clover Assistant to empower clinicians, not restrict access.
- Company states AI is core to Clover Assistant, used to improve care rather than deny it, unlike competitors.
- Garipalli views long-term competition as healthtech/AI-native startups, not traditional MA incumbents.

## SEC filing metadata
- accession: 0001801170-25-000217
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000217/0001801170-25-000217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000217/clov-20250811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-25-000217
- JSON: https://secwatch.observer/filing/0001801170-25-000217.json
- Plain text: https://secwatch.observer/filing/0001801170-25-000217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.